Full course description
This course is designed to reduce confusion and educate Naturopathic Doctors with regard to the clinical application of CBD and hemp-derived CBD products. You will explore utilizing CBD in a clinical practice with an evidence-based approach to clinical research investigating both CBD (substantive, but still emerging) and hemp-derived CBD products (limited). This activity does not discuss “marijuana”, other than to contrast it with hemp from a regulatory perspective. Important aspects of pharmacology, pharmacokinetics, pharmacodynamics, drug interactions, methods of administration and dosage will all be covered. The goal is to help clinicians understand the various indications for CBD, including, and especially, FDA-approved preparations of CBD for seizure disorders, schizophrenia and anxiety.
Course Learning Objectives
- Outline FDA’s concerns
- Review the current regulatory environment for CBD
- Understand various MOAs and pharmacokinetics
- Introduce the endocannabinoid system
- Describe the pharmacology of CBD
- Examine tolerability & safety studies
- Review drug interaction mechanisms and DDI studies
- Evaluate clinical trials w/ a focus on dosage
- Learn how to evaluate CBD products
Course CE Completion Requirements (1 CEU)
- You must complete the course materials by April 1, 2022.
- You must complete the course exam with a 75% or higher to pass.
- You must complete the course evaluation.
- To receive a CE certificate, you must have a approved credential.
About the Instructor
Jamie Corroon, ND, MPH is the founder and Medical Director of the Center for Medical Cannabis Education. Dr. Corroon is a licensed Naturopathic Doctor and clinical researcher. In addition, Dr. Corroon advises dietary supplement and Cannabis companies regarding science, regulation, and product development. Dr. Corroon is well published in the peer-review literature, with recent publications that investigate the clinical and public health implications of the broadening acceptance of Cannabis in society.